{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:18:36Z","timestamp":1778933916730,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejpb.2019.06.011","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T02:50:04Z","timestamp":1560307804000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model"],"prefix":"10.1016","volume":"142","author":[{"given":"D.","family":"Dahlgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lundqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tannergren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sj\u00f6gren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Sj\u00f6blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lennern\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.06.011_b0005","first-page":"2","author":"Sommansson","year":"2015","journal-title":"Acta Physiologica."},{"key":"10.1016\/j.ejpb.2019.06.011_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1748-1716.2007.01777.x","article-title":"Comparative study of the effect of luminal hypotonicity on mucosal permeability in rat upper gastrointestinal tract","volume":"193","author":"Pihl","year":"2008","journal-title":"Acta physiologica."},{"key":"10.1016\/j.ejpb.2019.06.011_b0015","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.molpharmaceut.7b00279","article-title":"Regional intestinal permeability in rats: a comparison of methods","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0020","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1021\/acs.molpharmaceut.7b00294","article-title":"In vivo mechanisms of intestinal drug absorption from aprepitant nanoformulations","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0025","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1053\/gast.2001.29605","article-title":"Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus","volume":"121","author":"Schwarz","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejpb.2019.06.011_b0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1748-1716.2005.01507.x","article-title":"Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine","volume":"186","author":"Nylander","year":"2006","journal-title":"Acta Physiologica."},{"key":"10.1016\/j.ejpb.2019.06.011_b0035","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1748-1716.2012.02411.x","article-title":"The selective cyclooxygenase-2 inhibitor parecoxib markedly improves the ability of the duodenum to regulate luminal hypertonicity in anaesthetized rats","volume":"205","author":"Sedin","year":"2012","journal-title":"Acta Physiologica."},{"key":"10.1016\/j.ejpb.2019.06.011_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1748-1716.2006.01649.x","article-title":"Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum","volume":"189","author":"Nylander","year":"2007","journal-title":"Acta Physiologica."},{"key":"10.1016\/j.ejpb.2019.06.011_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2018.07.057","article-title":"Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport","volume":"549","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0050","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.molpharmaceut.7b00353","article-title":"Preclinical effect of absorption modifying excipients on rat intestinal transport of five model compounds and the intestinal barrier marker 51Cr-EDTA","volume":"14","author":"Dahlgren","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.06.011_b0060","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/nmo.12410","article-title":"Quantifying the effects of inactin vs Isoflurane anesthesia on gastrointestinal motility in rats using dynamic magnetic resonance imaging and spatio-temporal maps","volume":"26","author":"Ailiani","year":"2014","journal-title":"Neurogastroenterol Motil."},{"key":"10.1016\/j.ejpb.2019.06.011_b0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-201X.1996.530287000.x","article-title":"Comparative study of the effects of nitric oxide synthase and cyclo-oxygenase inhibition on duodenal functions in rats anaesthetized with inactin, urethane or a-chloralose","volume":"158","author":"Sababi","year":"1996","journal-title":"Acta Physiologica."},{"key":"10.1016\/j.ejpb.2019.06.011_b0070","doi-asserted-by":"crossref","first-page":"G653","DOI":"10.1152\/ajpgi.1989.257.4.G653","article-title":"Effects of hydrochloric acid on duodenal and jejunal mucosal permeability in the rat","volume":"257","author":"Nylander","year":"1989","journal-title":"American J. Physiol. Gastrointestinal Liver Physiol."},{"key":"10.1016\/j.ejpb.2019.06.011_b0075","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/mp500834v","article-title":"Human in vivo regional intestinal permeability: quantitation using site-specific drug absorption data","volume":"12","author":"Sj\u00f6gren","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0080","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/acs.molpharmaceut.6b00515","article-title":"Regional intestinal permeability in dogs: biopharmaceutical aspects for development of oral modified-release dosage forms","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0085","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acs.molpharmaceut.6b00514","article-title":"Regional intestinal permeability of three model drugs in human","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0090","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.06.011_b0095","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1023\/B:PHAM.0000036921.87928.72","article-title":"Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction","volume":"21","author":"Letendre","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2019.06.011_b0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF01061689","article-title":"Formed and preformed metabolite excretion clearances in liver, a metabolite formation organ: studies on enalapril and enalaprilat in the single-pass and recirculating perfused rat liver","volume":"21","author":"de Lannoy","year":"1993","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0090-9556(25)07014-X","article-title":"Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration","volume":"16","author":"Foster","year":"1988","journal-title":"Drug Metabolism Disposit."},{"key":"10.1016\/j.ejpb.2019.06.011_b0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3109\/00498254.2010.538090","article-title":"Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol","volume":"41","author":"Yoon","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejpb.2019.06.011_b0115","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0022-3565(24)37527-5","article-title":"A new interpretation of salicylic acid transport across the lipid bilayer: implications of pH-dependent but not carrier-mediated absorption from the gastrointestinal tract","volume":"285","author":"Takagi","year":"1998","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.ejpb.2019.06.011_b0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1211\/0022357055786","article-title":"Investigation of oral bioavailability and brain distribution of the Ind (8)-Val conjugate of indinavir in rodents","volume":"57","author":"de Oliveira","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2019.06.011_b0125","unstructured":"FDA. Bioanalytical Method Validation - Guidance for Industry. 2018."},{"key":"10.1016\/j.ejpb.2019.06.011_b0130","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/00498250701704819","article-title":"Intestinal permeability and its relevance for absorption and elimination","volume":"37","author":"Lennernas","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejpb.2019.06.011_b0135","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.05.029","article-title":"The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs","volume":"547","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpb.2018.09.022","article-title":"Jejunal absorption of aprepitant from nanosuspensions: role of particle size, prandial state and mucus layer","volume":"132","author":"Roos","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejpb.2018.10.006","article-title":"Mechanistic modelling of intestinal drug absorption\u2013the in vivo effects of nanoparticles, hydrodynamics, and colloidal structures","volume":"133","author":"Roos","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2019.06.011_b0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1152\/physrev.00031.2014","article-title":"GLP-1, and PYY (3\u201336): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB","volume":"97","author":"Steinert","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejpb.2019.06.011_b0155","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1021\/jm9810102","article-title":"Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. a multivariate data analysis approach","volume":"41","author":"Winiwarter","year":"1998","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119302504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641119302504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:34:14Z","timestamp":1760546054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641119302504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":31,"alternative-id":["S0939641119302504"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.06.011","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}